NC
TMO icon

Northpointe Capital’s Thermo Fisher Scientific TMO Stock Holding History

Northpointe Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$2.29M Sell
7,874
-451
-5% -$129K 0.89% 59
2019
Q2 		$2.44M Buy
8,325
+706
+9% +$194K 0.78% 65
2019
Q1 		$2.08M Sell
7,619
-4,648
-38% -$1.16M 0.66% 70
2018
Q4 		$2.75M Sell
12,267
-260
-2% -$61K 0.62% 64
2018
Q3 		$3.06M Sell
12,527
-131
-1% -$30.1K 0.44% 108
2018
Q2 		$2.62M Buy
+12,658
New +$2.69M 0.35% 132
2018
Q1 		– Sell
-15,064
Closed -$2.86M – 189
2017
Q4 		$2.86M Sell
15,064
-311
-2% -$59.6K 0.32% 135
2017
Q3 		$2.91M Sell
15,375
-1,884
-11% -$341K 0.31% 131
2017
Q2 		$3.01M Buy
17,259
+754
+5% +$127K 0.32% 128
2017
Q1 		$2.54M Hold
16,505
– – 0.28% 136
2016
Q4 		$2.33M Sell
16,505
-465
-3% -$68.6K 0.23% 141
2016
Q3 		$2.7M Buy
16,970
+722
+4% +$111K 0.28% 135
2016
Q2 		$2.4M Buy
+16,248
New +$2.4M 0.28% 124
2016
Q1 		– Sell
-25,610
Closed -$3.13M – 266
2015
Q4 		$3.13M Hold
25,610
– – 0.41% 85
2015
Q3 		$3.13M Buy
25,610
+2,571
+11% +$335K 0.41% 86
2015
Q2 		$2.99M Buy
23,039
+3,814
+20% +$497K 0.35% 90
2015
Q1 		$2.58M Buy
19,225
+1,415
+8% +$182K 0.28% 121
2014
Q4 		$2.23M Buy
17,810
+1,508
+9% +$183K 0.27% 133
2014
Q3 		$1.98M Buy
16,302
+92
+0.6% +$11.2K 0.21% 139
2014
Q2 		$1.91M Buy
16,210
+6,623
+69% +$779K 0.18% 157
2014
Q1 		$1.15M Sell
9,587
-1,023
-10% -$122K 0.12% 177
2013
Q4 		$1.18M Sell
10,610
-260
-2% -$25.9K 0.1% 184
2013
Q3 		$1M Buy
+10,870
New +$983K 0.12% 184

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northpointe Capital's TMO Position: Q3 2019 in Review

Northpointe Capital reduced its Thermo Fisher Scientific (TMO) stake by 5.4% in Q3 2019, selling an estimated $129K and leaving 7,874 shares worth $2.29M. The position accounts for 0.89% of the portfolio, ranked #59.

Northpointe Capital first reported a position in TMO in Q3 2013 and has held it in 23 quarters since. The position peaked at $3.13M in Q4 2015. 1,545 funds tracked by Wall St. Rank hold TMO as of Q3 2019.

  • Northpointe Capital held 7,874 shares of Thermo Fisher Scientific worth $2.29M as of Q3 2019.
  • Northpointe Capital sold 451 Thermo Fisher Scientific shares in Q3 2019, an estimated $129K.
  • Thermo Fisher Scientific made up 0.89% of Northpointe Capital's portfolio in Q3 2019, its #59 holding.
  • Northpointe Capital first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 23 quarters since.
  • Northpointe Capital's Thermo Fisher Scientific position peaked at $3.13M in Q4 2015.
  • 1,545 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2019.

Based on Northpointe Capital's 13F filing for Q3 2019, filed 16 Oct 2019.